Psychiatric Euthanasia in Belgium

• Introduction
• Chapter 1 The Belgian Legal Landscape: Evolution of the 2002 Euthanasia Law
• Chapter 2 Unbearable Suffering: Deconstructing the Subjectivity of Psychic Pain
• Chapter 3 The Criterion of Incurability: Defining "No Prospect of Improvement" in Psychiatry
• Chapter 4 Decision-Making Capacity and Fluctuating Competence in Severe Mental Illness
• Chapter 5 Treatment Exhaustion: When Has Every Reasonable Option Truly Failed?
• Chapter 6 The Role of Time: Navigating Watchful Waiting and Mandatory Delays
• Chapter 7 Depression and the Wish to Die: Untangling Symptom from Authentic Autonomous Request
• Chapter 8 Personality Disorders and Relational Instability: Ethical Challenges in Assessment
• Chapter 9 Schizophrenia and Psychotic Disorders: Insight, Reality Testing, and Volition
• Chapter 10 Eating Disorders and Chronic Refusal: The Boundaries of Medical Futility
• Chapter 11 Trauma, Demoralization, and Social Suffering: Medicalizing the Non-Medical
• Chapter 12 The Clinician's Dual Role: Healer, Gatekeeper, and Accompanier
• Chapter 13 The Independent Consultant: Navigating the Second and Third Opinions
• Chapter 14 Conscientious Objection, Moral Distress, and Institutional Transfer
• Chapter 15 The Family’s Position: Collateral Suffering, Consultation, and Exclusion
• Chapter 16 Therapeutic Alliance Amidst a Request: Maintaining Hope While Respecting Autonomy
• Chapter 17 The Transferential Dynamic: Countertransference and Burnout in Psychiatric End-of-Life Care
• Chapter 18 Vulnerability and Power Dynamics: Socioeconomic Disadvantage in End-of-Life Choices
• Chapter 19 Palliative Psychiatry: An Emerging Paradigm or a Contradiction in Terms?
• Chapter 20 Oversight and Ambiguity: The Realities of the Federal Control and Evaluation Commission
• Chapter 21 Navigating Uncertainty: A Step-by-Step Ethical Decision-Making Framework
• Chapter 22 The Days Leading Up: Logistics, Protocols, and the Retractability of Consent
• Chapter 23 Bereavement and Moral Remainder: Supporting Families After Psychiatric Euthanasia
• Chapter 24 Comparative Perspectives: Lessons, Warnings, and International Divergences
• Chapter 25 Clarifications and Obscurities: The Future of Psychiatric Euthanasia

Few frontiers in contemporary bioethics evoke as much profound unease, clinical hesitation, and existential weight as the intersection of psychiatry and voluntary death. When Belgium enacted its landmark Euthanasia Law on May 28, 2002, it established a legal framework that did not distinguish between somatic illness and psychic agony. By recognizing that non-terminal, unbearable, and medically hopeless mental suffering could warrant medical assistance in dying, the statute fundamentally altered the therapeutic mandate of psychiatry. In the decades since, Belgium has served as an involuntary global laboratory. For some international observers, the Belgian practice represents the logical culmination of respect for patient self-determination—an empathic acknowledgement that the mind can fracture as irrecoverably as the body. For others, it signals a precarious erosion of medicine’s protective ethos, risking the abandonment of chronically distressed individuals under the banner of autonomous choice.

This book originates in the space between these polarized stances. It is written not to champion an ideological cause, nor to offer a polemical indictment, but to map the distinct ethical reasoning required when mental suffering drives a request for euthanasia. The statutory criteria—competence, voluntariness, unbearable suffering, and a medical condition without prospect of improvement—may read with deceptive clarity on paper. Within the psychiatric clinic, however, each of these concepts fractures under scrutiny. Unlike an advanced malignancy marked by measurable physical deterioration and predictable cellular trajectories, psychiatric conditions resist neat demarcations of irreversibility. The very organ through which distress is felt and evaluated is the organ generating the request. In this terrain, clinical judgment cannot rely on somatic heuristics; it demands a granular, vigilant, and morally strenuous framework of assessment.

A central premise of this work is that Belgian clinical practice both clarifies and obscures the essential weights that should guide end-of-life decisions. Where Belgian practice clarifies, it demonstrates that taking a patient’s wish to die seriously does not necessarily lead to hasty termination; paradoxically, the deep, non-coercive accompaniment inherent in an open assessment process can rebuild therapeutic alliances and revive a fractured will to live. It also proves that palliative approaches to mental illness—shifting the focus from curative exhaustion to comfort and harm reduction—can restore human dignity to those ground down by decades of unremitting distress. Yet, where Belgian practice obscures, it leaves unresolved foundational questions: How do we reliably separate an authentic, autonomous end-of-life request from the symptomatic hopelessness of severe affective illness? When does the respect for an individual's right to refuse further treatment slide into a clinical complicity with treatable despair? And how do institutional structures and socioeconomic vulnerabilities quietly exert pressure on the margin between enduring life and seeking release?

To confront these questions, this guide is crafted as a practical, ethically rigorous resource for three interconnected audiences: clinicians, families, and patients. For psychiatrists, physicians, and multidisciplinary care teams, it offers nuanced strategies for navigating the dual role of compassionate healer and statutory gatekeeper, addressing the intense countertransference, moral distress, and procedural ambiguity that inevitably arise. For families and loved ones, who frequently find themselves caught in the harrowing crossfire between unconditional support and profound anticipatory grief, it examines the relational dynamics, legal limitations, and lingering bereavement that accompany a state-sanctioned death. For patients who find themselves wrestling with refractory anguish, it provides an unvarnished mirror to their suffering, clarifying the stringent expectations of capacity, trial, and dialogue that authentic deliberation demands.

The tone throughout this volume is intentionally sober, clinically grounded, and philosophically rigorous. We move through the legal foundations and foundational clinical criteria, dissect specific diagnostic challenges ranging from affective and personality disorders to schizophrenia and chronic eating disorders, evaluate institutional governance, and ultimately present a structured ethical framework designed to assist decision-makers amidst irremediable uncertainty. At every turn, we examine the human cost of both action and inaction: the tragic error of prematurely ending a life that held latent potential for recovery, balanced against the prolonged, forced endurance of torment that medicine can no longer alleviate. By confronting both the illuminates and the shadows of the Belgian experience, this book seeks to bring ethical order to one of the most agonizing dilemmas in modern medicine.

When the Belgian Parliament passed the Act on Euthanasia on May 28, 2002, the atmosphere in the Palais de la Nation was charged with a mixture of progressive triumph and deep conservative apprehension. Belgium had become only the second country in the world, following a few months behind its northern neighbor, the Netherlands, to explicitly decriminalize the intentional termination of life by a physician at the request of a patient. Yet, the legislators who drafted the statute did something structurally unique that set their work apart from Dutch jurisprudence: they built a legal edifice grounded not in a classic defense of necessity (noodtoestand) or an uncodified medical exception, but in a positive statutory right structured around self-determination, carefully balanced against medical gatekeeping.

The political genesis of the law was inseparable from Belgium’s broader cultural transformations at the turn of the millennium. For over a century, Belgian politics had been defined by "pillarization," a system where social institutions—schools, trade unions, hospitals, and political parties—were organized along strict Catholic and secular-humanist ideological divides. By the late 1990s, these pillars were crumbling rapidly. The historic "rainbow coalition" led by Prime Minister Guy Verhofstadt, uniting liberals, socialists, and greens while banishing the Christian Democrats to the opposition benches for the first time in four decades, viewed modern bioethics legislation as a litmus test for social modernization. The coalition was eager to dismantle paternalistic legal relics and establish an ethic centered on personal autonomy, and the resulting euthanasia bill was its crowning legislative achievement.

From its very inception, the 2002 law made no fundamental legal distinction between physical and psychological suffering. Article 3, Paragraph 1 of the statute laid out the core conditions: the patient must be an adult or an emancipated minor (a scope that would undergo controversial expansion years later), legally competent and conscious at the moment of the request. The request had to be voluntary, well-considered, and repeated, made without any external pressure. Crucially, the patient had to find themselves in a medically hopeless situation of constant and unbearable physical or mental suffering that could not be alleviated, resulting from a serious and incurable disorder caused by illness or accident.

That brief, almost innocuous phrase—"physical or mental suffering" (fysiek of psychisch lijden in Dutch, souffrance physique ou psychique in French)—was not an accidental afterthought slipped in through an amendment. It was debated, defended, and preserved with rigorous intentionality. The drafters recognized that human agony does not politely segregate itself along Cartesian dualisms; an advanced oncological pathology induces acute psychological anguish, while severe psychiatric disease generates profound somatic sensations of torment. By inserting "or mental," the legislature ensured that patients whose suffering was entirely psychiatric in origin could theoretically seek the same legal relief as those with terminal cancer.

However, the drafters were not completely blind to the distinct risks posed by cases where the underlying pathology would not lead to death in short order. They created a bifurcated procedural framework, distinguishing between patients whose death is expected in the reasonably foreseeable future—the terminal cases—and those whose death is not anticipated in the short term, a category known under the statute as non-terminal cases. It is within this latter procedural tier that all purely psychiatric euthanasia requests naturally land.

For the non-terminal category, the law introduced three mandatory safeguards beyond the standard protocols. First, the physician must consult not one, but two independent physicians. One of these consultants must be a psychiatrist or a specialist in the pathology in question. Second, both independent consultants must examine the patient, confirm the medical futility of the condition, verify the unbearable nature of the suffering, and write independent reports that the attending physician must review before proceeding. Third, a mandatory cooling-off period was instituted: at least one full month must elapse between the patient’s written request and the act of euthanasia itself. The statute envisioned this delay as a structural circuit breaker, preventing impulsive, crisis-driven actions while giving all parties space to reflect, review, and reconsider.

To enforce these procedural standards, the 2002 Act established a dedicated regulatory body: the Federal Control and Evaluation Commission (Commission fédérale de contrôle et d’évaluation de l’euthanasie / Federale Controle- en Evaluatiecommissie). Composed of sixteen members—eight medical doctors, four professors of law or practicing lawyers, and four individuals drawn from fields concerned with the problems of incurably ill patients—the Commission was designed to reflect Belgium’s linguistic balance, with equal representation of French and Dutch speakers, as well as its pluralistic philosophical landscape.

The regulatory model adopted by the Belgian legislature was strictly retrospective. The law does not require clinicians to seek pre-authorization from a court, an ethics board, or an administrative committee before administering a lethal substance. Instead, the physician carries out the procedure and then, within four working days, submits a detailed, standardized registration document to the Commission. This document is split into two sections: an anonymous segment containing clinical details, diagnostic codes, and procedural timelines, and a sealed identifying segment containing the identities of the patient, the attending physician, and the consulting doctors. The Commission meets monthly to review the anonymous files, checking whether the statutory requirements were met. Only if a two-thirds majority finds significant irregularities or violations of the law is the sealed envelope opened, and the case referred to the public prosecutor.

In the early years following the law’s enactment, psychiatric euthanasia remained an exceptionally rare, almost theoretical phenomenon. Clinicians were hesitant, legal interpretations were cautious, and the medical establishment was preoccupied with integrating palliative care into standard hospital routines—a parallel legislative push that accompanied the euthanasia law under the Palliative Care Act of 2002. In the first official biennial reports published by the Federal Commission, notifications of euthanasia for psychiatric disorders hovered in the single digits, viewed by many practitioners as exceptional, tragic edge cases involving individuals who had endured decades of institutionalization without relief.

Yet the law was not static; it began to evolve both through legislative amendments and through the gradual accumulation of clinical precedent. A defining turning point came in February 2014, when the Belgian Parliament passed an amendment that captured global headlines: the extension of the euthanasia law to non-emancipated minors. Amidst international outcry, commentators often misunderstood the precise scope of this reform. The Belgian legislature had indeed removed the age limit, allowing children to request euthanasia, but it had attached strict, hyper-conservative guardrails. Unlike adults, a minor could only request euthanasia if they were in a terminal condition, facing imminent death, and suffering unbearable physical pain; psychiatric illness was explicitly barred as a permissible ground for a minor's request. Thus, while the 2014 amendment pushed the conceptual boundaries of the statute, it paradoxically fortified the distinction between somatic and psychological disease for patients under the age of eighteen.

While the statutory text remained largely unaltered for adults, the practical reality on the ground was shifting dramatically throughout the 2010s. The absolute number of euthanasia notifications across all categories steadily climbed, and with that general normalization came a noticeable rise in psychiatric requests. What had once been a negligible fraction of cases began to average between twenty and forty officially reported procedures per year. While this still accounted for less than two percent of total euthanasia cases in Belgium, it placed unprecedented scrutiny on the psychiatric profession and exposed the friction points inherent in applying a somatic legal blueprint to the labyrinth of mental illness.

The legal machinery faced its most significant institutional challenge between 2018 and 2020, culminating in a historic criminal trial that laid bare the legal ambiguities of psychiatric end-of-life care. The case centered on the death of Tine Nys, a thirty-eight-year-old woman who had been diagnosed with Asperger’s syndrome and a history of severe, chronic mental distress, and who was granted euthanasia in 2010. Eight years after her death, following persistent complaints from her family who argued that the procedure had been handled with reckless haste and procedural non-compliance, three physicians—the attending doctor who administered the lethal injection, the psychiatrist who served as a consultant, and the patient’s former general practitioner—were indicted for the crime of "poisoning," a capital offense under Belgian criminal law carrying a life sentence.

The Cour d’assises of Ghent, a jury court reserved for the most serious crimes, became the arena for an extraordinary, agonizing public debate in January 2020. Over several weeks, the court parsed the fine print of the 2002 law with forensic intensity. The central legal questions were razor-sharp: Had the doctors truly consulted an independent psychiatrist, or was the consultant biased? Did the patient meet the threshold of an "incurable condition" when the diagnosis of autism spectrum disorder had been made only months before her death? Was the cooling-off period observed in spirit or merely in form? And, critically, did the statutory definition of euthanasia permit room for procedural shortcuts?

The trial exposed an uncomfortable truth about the Belgian statute: its enforcement framework was fundamentally binary. In the Belgian criminal code, there was no intermediate offense for "euthanasia with administrative non-compliance" or "negligent performance of an end-of-life consultation." If a doctor violated any substantive requirement of the 2002 Act, the protective legal immunity afforded by the statute was entirely stripped away, instantly rendering the lethal act an intentional homicide, prosecuted as poisoning.

Ultimately, the jury acquitted all three physicians of the murder charges, bringing immense relief to the Belgian medical establishment, which had warned that a conviction would trigger a complete cessation of end-of-life care for vulnerable patients. However, the civil branch of the case continued to grind through the courts. The Belgian Court of Cassation later ruled that the civil claims against the attending physician required reconsideration, establishing that even if a doctor’s procedural failings did not rise to the level of criminal murder, they could still constitute civil negligence, leaving the clinician liable for damages to surviving family members. The trial permanently dissolved the sense of legal invulnerability that had previously enveloped Belgian clinicians, forcing every psychiatrist in the country to recognize that end-of-life assessments were subject to stringent judicial retrospection.

The reverberations of the Nys trial accelerated internal demands for greater regulatory clarity. In 2017, the Flemish Association for Psychiatry (Vlaamse Vereniging voor Psychiatrie, or VVP) had already taken the unprecedented step of publishing comprehensive clinical guidelines for handling euthanasia requests in psychiatry. The VVP guidelines did not seek to undermine the law, but rather to construct the clinical scaffolding that the 2002 statute lacked. Recognizing that the statutory requirement of a one-month delay was wildly inadequate for complex psychiatric dynamics, the VVP recommended that psychiatric assessments should almost invariably extend across a minimum of six months to a year, and that a minimum of two separate psychiatric opinions, rather than just one, should be standard practice.

This professional self-regulation represented a tacit acknowledgment of the gap between broad statutory legality and defensive clinical ethics. What the law permitted in thirty days was increasingly seen by professional bodies as ethically precarious, if not outright dangerous, when applied to patients suffering from personality disorders, major depression, or complex relational trauma. Belgian law established the outer boundaries of criminal liability, but the psychiatric community began to assert that the true standards of practice had to be far more rigorous, time-intensive, and demanding than the legal minimum.

Simultaneously, the European Court of Human Rights (ECtHR) entered the fray, examining the architecture of Belgian end-of-life oversight. In the 2022 landmark case of Mortier v. Belgium, the Strasbourg court evaluated the death of Godelieva De Troyer, a woman with a prolonged history of treatment-resistant depression who underwent euthanasia in 2012 without the knowledge of her adult children. Her son, Tom Mortier, argued that Belgium had failed to protect his mother’s right to life under Article 2 of the European Convention on Human Rights and had failed to conduct an effective investigation into the circumstances of her death.

The ECtHR delivered a nuanced, highly significant judgment. On the core substantive issue, the court found no violation of the right to life regarding the legislative framework itself; it reaffirmed that sovereign states enjoy a wide margin of appreciation in regulating end-of-life practices, confirming that psychiatric suffering could legitimately fall within an assisted dying framework provided robust safeguards were maintained. However, the court found a procedural violation of Article 2 concerning the post-factum oversight exercised by the Federal Control and Evaluation Commission.

The European Court highlighted a glaring conflict of interest embedded within the Commission's working methods. In the Mortier case, the attending physician who had administered euthanasia was also a sitting, prominent member of the Federal Commission. Although he had recused himself from the room when his specific file was formally discussed—as required by internal Commission rules—the ECtHR determined that the mere presence of the treating physician within the regulatory body, coupled with the lack of anonymity during actual deliberations once a case raised questions, undermined the operational independence required by human rights standards. The post-factum review could not be seen as truly impartial when members were essentially reviewing the clinical decisions of their immediate peers and colleagues without independent oversight.

The Mortier ruling put significant pressure on the Belgian legislature to modernize the 2002 framework, bringing institutional reform from the theoretical realm directly into parliamentary committee rooms. Legislative debates gained renewed urgency, centering on proposals to overhaul the composition of the Federal Commission, mandate absolute anonymity throughout all phases of review, and formalize an appeals process for contested cases. The legal architecture that had seemed progressive and definitive in the early 2000s was showing its age, struggling to reconcile the delicate balance between compassionate autonomy and administrative rigor.

Parallel to these institutional challenges, another complex legal interface emerged: the relationship between euthanasia law and the legislation governing involuntary psychiatric commitment (Wet betreffende de bescherming van de persoon van de geesteszieke). In clinical reality, these two frameworks frequently collide. A patient may express an active, persistent death wish that leads to an involuntary psychiatric hold on grounds of acute danger to themselves, while simultaneously demanding an orderly evaluation for voluntary medical death under the 2002 Act.

Under Belgian law, the existence of an involuntary commitment order does not, by default, strip an individual of their legal capacity to make a euthanasia request. The legal tests are legally separate: an individual may lack the capacity to safely live unsupervised in the community, yet retain the specific decision-making competence required to articulate an enduring, autonomous request for the termination of their life. Navigating this intersection requires clinicians to perform a delicate legal and psychiatric tightrope walk. They must maintain protective custody to prevent chaotic, non-reflective self-harm, while simultaneously leaving the procedural door open for a sober, prolonged evaluation of a formal euthanasia request, provided the patient can demonstrate intact decision-making capacity regarding their prognosis and options.

The Belgian legal landscape has thus evolved from an optimistic declaration of secular patient self-determination into an intricate, legally contested, and hyper-regulated clinical minefield. The foundational text of the May 28, 2002 Act remains the operational bedrock, standing on its original four pillars: competence, voluntariness, unbearable suffering, and a medically hopeless condition caused by a serious illness. Yet this statutory foundation is now surrounded by an ever-thickening network of professional guidelines, appellate case law, European human rights jurisprudence, and heightened public vigilance.

For the clinician standing at the bedside or sitting in the consultation room, the law provides an essential perimeter, defining what is legally permissible and protecting against criminal sanction. But it offers remarkably little guidance on the day-to-day moral quandaries that emerge once the legal doors are unlocked. The statute states that the suffering must be "unbearable," but it offers no psychometric scale to measure it; it demands that the condition have "no prospect of improvement," but leaves the definition of curability in the hands of fallible human prognostication. The evolution of the Belgian law has clarified the legal mechanics of how a life may be lawfully ended, but in doing so, it has illuminated the profound clinical responsibility of determining when a psychological state should be judged entirely beyond medical reclamation.